Omalizumab

3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Omalizumab
Treatment and conditionWhere it standsTrials
Omalizumab for anaphylaxisTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Omalizumab for food hypersensitivityTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Omalizumab for peanut hypersensitivityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1